62 phenotypes from 4 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cnot3em1(IMPC)Rbrc/Cnot3+ C57BL/6NJcl-Cnot3em1(IMPC)Rbrc/Rbrc	abnormal behavior	J:211773
	abnormal kidney morphology	J:211773
	abnormal liver morphology	J:211773
	abnormal male genitalia morphology	J:211773
	abnormal uterus morphology	J:211773
	absent external male genitalia	J:211773
	decreased bone mineral content	J:211773
	decreased bone mineral density	J:211773
	decreased circulating triglyceride level	J:211773
	decreased locomotor activity	J:211773
	hydrometra	J:211773
	hyperactivity	J:211773
	improved glucose tolerance	J:211773
	increased circulating bilirubin level	J:211773
	increased thigmotaxis	J:211773
Cnot3tm1.1Kjkb/Cnot3tm1.1Kjkb A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ involves: 129P2/OlaHsd * C57BL/6 * FVB/N	congestive heart failure	J:260012
	premature death	J:260012
Cnot3tm1.1Kjkb/Cnot3tm1.1Kjkb Tg(Ckmm-cre)5Khn/0 involves: 129P2/OlaHsd * C57BL/6 * FVB	cardiac muscle necrosis	J:260012
	cardiomyopathy	J:260012
	decreased cardiac muscle contractility	J:260012
	decreased myocardial fiber number	J:260012
	enlarged heart	J:260012
	increased heart weight	J:260012
	irregular heartbeat	J:260012
	normal muscle phenotype	J:260012
	premature death	J:260012
	prolonged QT interval	J:260012
Cnot3tm1.1Tya/Cnot3+ B6.129P2(Cg)-Cnot3tm1.1Tya	abnormal bone mineralization	J:206802
	abnormal osteoclast differentiation	J:206802
	abnormal skeleton development	J:206802
	abnormal trabecular bone morphology	J:206802
	decreased birth body size	J:180033
	decreased body fat mass	J:180033
	decreased body length	J:180033
	decreased body weight	J:180033
	decreased bone mineral density	J:206802
	decreased bone trabecula number	J:206802
	decreased brown fat cell size	J:180033
	decreased circulating glucose level	J:180033
	decreased circulating triglyceride level	J:180033
	decreased compact bone thickness	J:206802
	decreased fasting circulating glucose level	J:180033
	decreased percent body fat/body weight	J:180033
	decreased subcutaneous adipose tissue amount	J:180033
	decreased susceptibility to diet-induced hepatic steatosis	J:180033
	decreased susceptibility to diet-induced obesity	J:180033
	decreased trabecular bone mass	J:206802
	decreased trabecular bone thickness	J:206802
	decreased white fat cell size	J:180033
	improved glucose tolerance	J:180033
	increased bone resorption	J:206802
	increased insulin sensitivity	J:180033
	increased osteoclast cell number	J:206802
	increased oxygen consumption	J:180033
	osteoporosis	J:206802
	small liver	J:180033
Cnot3tm1.1Tya/Cnot3tm1.1Tya B6.129P2(Cg)-Cnot3tm1.1Tya	embryonic lethality, complete penetrance	J:180033
Cnot3tm1Pngr/Cnot3+ B6.Cg-Cnot3tm1Pngr	abnormal cardiovascular system physiology	J:167954
	abnormal heart morphology	J:167954
	cardiac fibrosis	J:167954
	cardiac hypertrophy	J:167954
	decreased cardiac muscle contractility	J:167954
	decreased left ventricle developed pressure	J:167954
	decreased ventricle muscle contractility	J:167954
	increased heart left ventricle size	J:167954
	increased heart weight	J:167954
Cnot3tm1Pngr/Cnot3tm1Pngr B6.Cg-Cnot3tm1Pngr	abnormal inner cell mass morphology	J:167954
	embryonic lethality at implantation, complete penetrance	J:167954